Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Gene therapy for cystic fibrosis.

Mueller C, Flotte TR.

Clin Rev Allergy Immunol. 2008 Dec;35(3):164-78. doi: 10.1007/s12016-008-8080-3. Review.

PMID:
18600482
2.

Clinical gene therapy using recombinant adeno-associated virus vectors.

Mueller C, Flotte TR.

Gene Ther. 2008 Jun;15(11):858-63. doi: 10.1038/gt.2008.68. Epub 2008 Apr 17. Review.

PMID:
18418415
3.

Delivering genes to the organ-localized immune system: long-term results of direct intramarrow transduction.

Louboutin JP, Liu B, Chekmasova AA, Reyes BA, van Bockstaele EJ, Strayer DS.

J Gene Med. 2007 Oct;9(10):843-51.

PMID:
17694566
4.

Lysozyme secretion by submucosal glands protects the airway from bacterial infection.

Dajani R, Zhang Y, Taft PJ, Travis SM, Starner TD, Olsen A, Zabner J, Welsh MJ, Engelhardt JF.

Am J Respir Cell Mol Biol. 2005 Jun;32(6):548-52. Epub 2005 Mar 3.

5.

Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.

Sirninger J, Muller C, Braag S, Tang Q, Yue H, Detrisac C, Ferkol T, Guggino WB, Flotte TR.

Hum Gene Ther. 2004 Sep;15(9):832-41.

PMID:
15353038
6.

Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors.

Flotte TR.

Gene Ther. 2004 May;11(10):805-10. Review. No abstract available.

PMID:
15042119
7.

Current status of gene therapy for inherited lung diseases.

Driskell RA, Engelhardt JF.

Annu Rev Physiol. 2003;65:585-612. Epub 2002 May 1. Review.

8.

Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis.

Ferrari S, Geddes DM, Alton EW.

Adv Drug Deliv Rev. 2002 Dec 5;54(11):1373-93. Review.

PMID:
12458150
9.

Gene therapy progress and prospects: cystic fibrosis.

Griesenbach U, Ferrari S, Geddes DM, Alton EW.

Gene Ther. 2002 Oct;9(20):1344-50. Review.

10.

What can SV40-derived vectors do for gene therapy?

Strayer DS, Zern MA, Chowdhury JR.

Curr Opin Mol Ther. 2002 Aug;4(4):313-23. Review.

PMID:
12222869
11.

Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors.

Strayer D, Branco F, Zern MA, Yam P, Calarota SA, Nichols CN, Zaia JA, Rossi J, Li H, Parashar B, Ghosh S, Chowdhury JR.

Mol Ther. 2002 Aug;6(2):227-37.

PMID:
12161189
12.

Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells.

Egan ME, Glöckner-Pagel J, Ambrose C, Cahill PA, Pappoe L, Balamuth N, Cho E, Canny S, Wagner CA, Geibel J, Caplan MJ.

Nat Med. 2002 May;8(5):485-92.

PMID:
11984593
13.

Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae.

Pelkmans L, Püntener D, Helenius A.

Science. 2002 Apr 19;296(5567):535-9.

14.

Recombinant adeno-associated virus gene therapy for cystic fibrosis and alpha(1)-antitrypsin deficiency.

Flotte TR.

Chest. 2002 Mar;121(3 Suppl):98S-102S. No abstract available.

PMID:
11893723
15.

Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.

Flotte TR.

Curr Opin Mol Ther. 2001 Oct;3(5):497-502. Review.

PMID:
11699895
16.

A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis.

Ruiz FE, Clancy JP, Perricone MA, Bebok Z, Hong JS, Cheng SH, Meeker DP, Young KR, Schoumacher RA, Weatherly MR, Wing L, Morris JE, Sindel L, Rosenberg M, van Ginkel FW, McGhee JR, Kelly D, Lyrene RK, Sorscher EJ.

Hum Gene Ther. 2001 May 1;12(7):751-61.

PMID:
11339892
17.

Improved activity of an actin-resistant DNase I variant on the cystic fibrosis airway secretions.

Zahm JM, Debordeaux C, Maurer C, Hubert D, Dusser D, Bonnet N, Lazarus RA, Puchelle E.

Am J Respir Crit Care Med. 2001 Apr;163(5):1153-7.

PMID:
11316652
18.

Generation of recombinant SV40 vectors for gene transfer.

Strayer DS, Lamothe M, Wei D, Milano J, Kondo R.

Methods Mol Biol. 2001;165:103-17. No abstract available.

PMID:
11217380
19.

Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients.

Virella-Lowell I, Poirier A, Chesnut KA, Brantly M, Flotte TR.

Gene Ther. 2000 Oct;7(20):1783-9.

20.

Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice.

Akinbi HT, Epaud R, Bhatt H, Weaver TE.

J Immunol. 2000 Nov 15;165(10):5760-6.

Items per page

Supplemental Content

Write to the Help Desk